Ehave Archives

Psychedelics News

Ehave

Press Releases

12 Mar 2021

Ehave CEO Benjamin Kaplan to be Featured on Psychedelic Spotlight Segment of New to the Street Airing on NewsMax on Sunday March 14th at 10:00 AM EST and Fox Business March 15th at 7:30 PM EST

MIAMI, March 12, 2021 (GLOBE NEWSWIRE) — Ehave, Inc....

By Microdose

Press Releases

3 Mar 2021

Ehave Inc. Files for KetaDash Trademark and to Uplist its Shares to the OTCQB

MIAMI, March 03, 2021 (GLOBE NEWSWIRE) — Ehave, Inc....

By Microdose

Press Releases

26 Feb 2021

Ehave Inc. Reaches Milestone; Ketamine IV Therapy Provider KetaDASH to Launch Beta in Second Quarter 2021

MIAMI, Feb....

By Microdose

Press Releases

17 Feb 2021

Psychedelic Partnership Reached, Ehave Inc. and Brain Scientific Sign Memorandum of Understanding to Map Brain Response to Psychedelic Treatment, Collaborate in the Development of Neural Net Algorithms for the Psychedelic Mental Health Sector, E-Tattoo Technology is Expected to Provide Continuous Monitoring

Ehave, Inc....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

27 Jan 2021

Ehave Looks to Expand KetaDASH to Palliative Care

MIAMI, Jan....

By Microdose

Press Releases

25 Jan 2021

Ehave, Inc. Utilizes Artificial Intelligence and Machine Learning for Big Data Management in Mental Healthcare

MIAMI, Jan....

By Microdose

Press Releases

22 Jan 2021

Ehave Closes Transaction to Acquire CureDash Assets, Adds KetaDASH Home Delivery Service for Ketamine Clinics

MIAMI, Jan....

By Microdose

Press Releases

21 Jan 2021

Ehave Revolutionizes Patient Medical Records for Psychedelic Mental Health

Medical records platform for psychedelic mental health to be available February 1 as a Plugin to the Ehave Dashboard....

By Microdose

Press Releases

20 Jan 2021

Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector

MIAMI, Jan....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result